Dr. RR Baliga's 'Podkast for the Kurious Doc'
Bertrand Russell showed that clear thinking is a moral act š§ ⨠As a founder of analytic philosophy, he taught us to question assumptions, sharpen language, and let logic guide both ideas and action šš From Principia Mathematica to public debates on freedom and peace, Russell reminds us that clarity, courage, and doubt belong together šļøš
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
š§ š©ø A finger-prick may change how we detect Alzheimerās disease. A new Nature Medicine study shows that dried capillary blood spots can reliably measure key Alzheimerās biomarkersāp-tau217, GFAP, and neurofilament lightāwith strong concordance to venous plasma and cerebrospinal fluid results. š In the DROP-AD multicenter study (7 sites, 337 participants), capillary p-tau217 correlated strongly with plasma (rā0.74) and predicted amyloid pathology with good accuracy (AUC ā0.86). š Why this matters: ⢠Enables minimally invasive, scalable, and potentially remote...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
𧬠Why Coronary Artery Disease Runs in Families Coronary artery disease is not just lifestyleāit is deeply genetic. Rare monogenic disorders like familial hypercholesterolemia and hundreds of common variants together shape lifelong risk, with polygenic risk scores identifying individuals whose inherited risk rivals traditional factors š«. The good news: genetic risk is modifiable. Early LDL lowering, healthy lifestyles, and precision prevention deliver the greatest benefit in those at highest inherited risk š¬. A timely synthesis from The New England Journal of...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
š§¬āļø Cancer and Acute Coronary Syndromes: Precision Where It Matters Most As cancer survival improves, more patients live long enough to face acute coronary syndromes (ACS)āoften with competing risks of death, bleeding, and ischaemia. Yet these patients have been largely excluded from ACS trials, leaving clinicians to navigate uncertainty. A landmark Lancet study introduces ONCO-ACS, the first cancer-specific, externally validated risk tool that simultaneously predicts 6-month mortality, major bleeding, and ischaemic events using 11 routine admission variables. šš§ ...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
š« Rethinking DCD Heart Transplantation A new JAMA Original Investigation reports encouraging early outcomes using rapid recovery with extended ultraoxygenated preservation (REUP) for donation after circulatory death (DCD) heart transplantationāwithout donor heart reanimation or machine perfusion. š¬ In a 24-patient case series, REUP achieved 96% 30-day survival, low primary graft dysfunction (4%), and minimal early rejection, even with older donors and prolonged ischemic times. āļø By avoiding reanimation, REUP may reduce ethical concerns, cost, and logistical...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
ā°š§¬ Timing matters in cancer. A superb JCI Review, Rhythms of risk: the intersection of clocks, cancer, and chronotherapy, shows how circadian clocks regulate cell cycle, DNA repair, metabolism, immunity, hypoxia, and even metastasisāand how circadian disruption (e.g., night-shift work) can reshape cancer risk and treatment response. āļøš The takeaway: clock biology is context-specific, and aligning therapy with circadian phase may enhance efficacy while reducing toxicityāan underused lever in precision oncology. šÆ Worth a careful read for clinicians, scientists, and...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
š« Residual Risk in Coronary Artery Disease Even after āoptimalā therapy, many patients remain at risk. Why? Because atherosclerosis is more than LDLāitās thrombosis š©ø, inflammation š„, and metabolism āļø working in concert. This FAQ-based slide deck distills contemporary insights on residual thrombotic, lipid, metabolic, and inflammatory risk, and highlights emerging therapiesāfrom dual-pathway inhibition š to GLP-1 receptor agonists 𧬠and colchicineāthat help close the gap between treatment and outcomes. š Key message: precision, not complacency....
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
Swami Vivekananda reminded the world that spiritual strength and social service are inseparable šļøš„ From Chicago in 1893 to Indiaās national awakening, his message was simple yet radical: each soul is potentially divineāand serving humanity is serving the Divine šš¤ More than a monk or philosopher, Vivekananda remains a timeless call to courage, compassion, and inner awakening āØš
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
š«š§ š”ļø Sense. Signal. Scar. A striking Cell study reframes myocardial infarction as a systems disease, not a heart-only event. Using single-cell and spatial transcriptomics in murine MI, the authors identify a triple-node heartābraināimmune loop: TRPV1-positive vagal sensory neurons (injury sensing) ā hypothalamic paraventricular nucleus AT1aR neurons (central integration) ā superior cervical ganglion IL-1β signaling (sympatheticāimmune effector arm). Intervening at any node improved ejection fraction, reduced infarct size, and normalized autonomic...
info_outlineDr. RR Baliga's 'Podkast for the Kurious Doc'
š¦µš Restless Legs Syndrome: more than a sleep complaint RLS affects ~3% of adults and is frequently missed or misdiagnosed as insomnia or anxiety. The latest evidence underscores three practical shifts: think iron (even when ānormalā), choose gabapentinoids first, and beware dopaminergic augmentation. For internists and frontline clinicians, recognizing RLS early can meaningfully improve sleep, mood, and quality of lifeāand may even reduce downstream cardiovascular risk. š§ š©ŗš¤ #RestlessLegsSyndrome #SleepMedicine #InternalMedicine #IronDeficiency...
info_outlineš§ š©ø A finger-prick may change how we detect Alzheimerās disease.
A new Nature Medicine study shows that dried capillary blood spots can reliably measure key Alzheimerās biomarkersāp-tau217, GFAP, and neurofilament lightāwith strong concordance to venous plasma and cerebrospinal fluid results.
š In the DROP-AD multicenter study (7 sites, 337 participants), capillary p-tau217 correlated strongly with plasma (rā0.74) and predicted amyloid pathology with good accuracy (AUC ā0.86).
š Why this matters:
⢠Enables minimally invasive, scalable, and potentially remote testing
⢠Expands access for population screening, prevention trials, and underserved groups (including Down syndrome)
⢠Moves us closer to earlier, equitable detectionāthough not yet ready for routine clinical decision-making
Small drop. Big signal. The future of Alzheimerās research may be at our fingertips. āØ